The One Liver Supplement With Actual Trial Data Behind It

Silymarin, the active extract from milk thistle seeds, is one of the few "liver support" supplements that has actually accumulated a real body of randomized controlled trial evidence — and that evidence points toward a genuine, if modest, effect.

The evidence base is unusually large

A systematic review of 29 randomized controlled trials spanning 1992 to 2023, encompassing 3,846 participants across diverse liver conditions, found that 65.5% of studies reported reduced liver enzyme levels with silymarin supplementation.¹ That's a meaningfully larger and more consistent trial base than most single-ingredient supplements ever accumulate.

Protective effects on drug-induced liver injury

A meta-analysis of five randomized controlled trials totaling 1,198 patients found silymarin significantly reduced the occurrence of drug-induced liver injury at week 4, with measurable protective effects on ALT, AST, and ALP levels.² A separate randomized controlled trial in patients with fatty liver disease who were bariatric surgery candidates found significant improvement in liver aminotransferases after just two months of milk thistle powder supplementation.³

What this doesn't mean

This is enzyme and steatosis improvement in specific clinical contexts — antituberculosis drug exposure, chronic fatty liver disease, pre-surgical patients — not a general "detox" claim for people with normal liver function. The trials that show benefit are almost all in people with some existing liver stress, not healthy livers being optimized further.

The practical takeaway

• Silymarin (standardized milk thistle extract) has one of the more consistent trial records of any liver supplement
• Benefits are shown in people with existing liver enzyme elevation or fatty liver disease, not as a general wellness "detox"
• It's a standardized extract being tested, not raw milk thistle tea or loose herb — dosing and formulation matter